Report #2862737

Received Oct 2, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: KS
Recovered: Unknown
Vaccinated: Sep 17, 2025
Onset: Sep 17, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	1	Z004302	—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No additional AE; Nurse calling to report administering a dose of CAPVAXIVE after experiencing a temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 17-Sep-2025, the patient was vaccinated with a dose of Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) injection 168 mcg/ml (lot #Z004302 with expiration date reported as and confirmed to be 04-Sep-2026) (dose, route of administration and vaccination site were not reported) administered for prophylaxis. The dose of Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was administered after experiencing a temperature excursion (TE) (temperature: 50.3F; time frame: 154 hours 0 minutes 0 seconds; previous temperature excursion: no) (product storage error). The TE assessment was not supported. No additional information was provided. No additional adverse event (AE) or product quality complaint (PQC) was reported (no adverse event).